Imperva (NASDAQ:IMPV) has been given an average rating of “Hold” by the nineteen analysts that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $53.08.

A number of analysts have recently issued reports on IMPV shares. Morgan Stanley lifted their price objective on shares of Imperva from $37.00 to $39.00 and gave the stock an “underweight” rating in a report on Friday, February 9th. BidaskClub raised shares of Imperva from a “hold” rating to a “buy” rating in a report on Tuesday, April 17th. ValuEngine raised shares of Imperva from a “sell” rating to a “hold” rating in a report on Thursday, February 15th. DA Davidson started coverage on shares of Imperva in a report on Tuesday, April 10th. They set a “buy” rating and a $56.00 price objective for the company. Finally, Evercore ISI set a $56.00 price objective on shares of Imperva and gave the stock a “buy” rating in a report on Friday, February 9th.

Imperva traded down $0.75, hitting $48.85, during trading hours on Thursday, MarketBeat reports. The stock had a trading volume of 208,200 shares, compared to its average volume of 376,941. Imperva has a one year low of $37.17 and a one year high of $52.40. The company has a market cap of $1.70 billion, a price-to-earnings ratio of -174.46 and a beta of 1.69.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Thursday, April 26th. The software maker reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.07. Imperva had a negative net margin of 3.00% and a negative return on equity of 1.63%. The company had revenue of $84.24 million during the quarter, compared to the consensus estimate of $83.77 million. During the same period in the previous year, the firm posted $0.09 EPS. The firm’s revenue was up 16.5% compared to the same quarter last year. sell-side analysts forecast that Imperva will post -0.61 earnings per share for the current fiscal year.

A number of large investors have recently modified their holdings of the stock. Xact Kapitalforvaltning AB purchased a new position in Imperva in the 1st quarter worth $205,000. Royal Bank of Canada raised its position in Imperva by 99.4% in the 1st quarter. Royal Bank of Canada now owns 2,794 shares of the software maker’s stock worth $122,000 after purchasing an additional 1,393 shares during the period. Legal & General Group Plc raised its position in Imperva by 2,341.6% in the 1st quarter. Legal & General Group Plc now owns 406,445 shares of the software maker’s stock worth $17,599,000 after purchasing an additional 389,798 shares during the period. Hellman Jordan Management Co. Inc. MA purchased a new position in Imperva in the 1st quarter worth $915,000. Finally, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new position in Imperva in the 1st quarter worth $827,000.

Imperva Company Profile

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.